BMS-986460

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Healthy VolunteersMetastatic Castration-resistant Prostate Cancer

Phase 1

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

RecruitingNCT06067841

Bristol-Myers SquibbMetastatic Castration-resistant Prostate Cancer

Start: 2023-10-18End: 2031-07-27Target: 140Updated: 2026-08-10

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

CompletedNCT06877702

Bristol-Myers SquibbHealthy Volunteers

Start: 2025-03-19End: 2025-12-17Updated: 2026-01-20